Amedica (AMDA) Misses Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Amedica Corporation Reports Second Quarter 2016 Financial Results
August 11, 2016 4:30 PM EDTSALT LAKE CITY, UT -- (Marketwired) -- 08/11/16 -- Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced financial results for the second quarter ended June 30, 2016.
Recent Company Highlights
Decreased year-to-date operational cash burn by 55% Completed $12.7 million public offering and reduced total debt principal balance to $10 million Submitted response to FDA in support of its application seeking clearance to commercialize its composite cervical interbody fusion device Featured unique silicon nitride attributes in several leading industry events... More